Download NSG 550 (NSG550) Exam 2 with accurate detailed answers and more Exams Nursing in PDF only on Docsity!
NSG|! 550:|! Exam|! 2 |! with|! accurate|!
detailed|! answers
- Pulmonary |! Function |! Tests/Spirometry: |! What |! can |! cause |! it |! to |! vary?: |! Age |! Sex Heigh t |! Weigh t
- Pulmonary |! Function |! Tests/Spirometry: |! Used |! to |! evaluate: |! Peop|! eval|! of|! lungs |! and |! pulmonary |! reserve response |! to |! bronchodilator |! therapy
differentiate |! between |! restrictive |! and |! obstructive |! chronic |! pulmonary |! disease |! Determine |! capacity |! of |! lungs Inhalation |! allergy |! tests
- Pulmonary |! Function|! Tests/Spirometry:|! What |! tests |! do |! they |! include?: |! Spirom- |! etry Airflow|! measurement |! Lung |! volume Lung |! capacity
- Forced |! Vital |! Capacity |! (FVC): |! Amount |! of |! air |! that |! can |! be |! forcefully |! expelled |! from |! a |! maximally |! inflated |! lung |! position.
- What |! does |! a|! reduced |! forced |! vital|! capacity |! suggest?: |! Obstructive|! and|!
- What |! is |! a |! normal |! FEV1/FVC |! ratio |! in |! obstructive |! lung |! disease?: |! Less |! than |! 80%
- Under |! what |! condition |! will |! the |! FEV1 |! value |! reliably |! improve?: |! With |! bron- |! chodilator |! therapy |! with |! a |! spastic |! component |! to |! obstructive |! pulmonary |! disease |! exists.
- Normal |! results |! of |! Spirometry: |! Greater |! than |! 80% |! of |! expected |! value
- Airflow |! rate: |! When |! is |! it |! considered |! diminished?: |! Less |! than |! 60% |! of |! normal.
- What |! helps |! to |! increase |! airflow |! rate |! and |! by |! how |! much?: |! 20% |! by |! with |! bron- |! chodilator
- Diagnosis |! of |! COPD |! requires |! what?: |! Demonstration |! of |! persistent |! airflow |!
limi- |! tation |! based |! on |! spirometry |! testing. After |! bronchodilator, |! FEV1/FVC |! of |! less |! than |! 70%.
- Classification |! of |! COPD |! severity |! is |! based |! on |! what?: |! Assessment |! of |! spirom- |! etry |! testing |! at |! regular |! intervals
- COPD |! Risk |! factors: |! Smoking |! Pollution |! exposure Genetic |! predispostion
- How |! does |! COPD |! compare |! with |! asthma?: |! Onset |! later |! in |! life. |! Slower |! progression |! of |! symptoms. Poorer |! response |! to |! inhaled |! therapy.
- Polysomnography: |! Sleep|! study
therapeutic |! procedures
- What |! can |! you |! use |! a |! bronchoscopy |! for?: |! Visualization |! of |! a |! tracheobronchial |! tree Transbronchial|! and|! Endobronchial|! biopsy |! Bronchoalveolar |! lavage Removal|! of|! foreign|! bodies |! Clots Mucus |! plugs Deployment|! of|! metallic|! stents. |! Aspiration |! of |! deep |! sputum |! Bleeding |! control
- What |! are |! some |! indications |! of |! bronchoscopy?: |! hemoptysis |! malignancy interstitial|! lung|! disease |! pulmonary |! infections |! Pleural |! effusion
than |! 3
- What |! conditions |! are |! exudates |! most |! often |! found |! in?:|! Inflammatory |! Infectious Neoplastic
- What |! is |! the |! appearance |! of |! exudates?: |! Cloudy/turbid |! Increased |! WBC Protein|! more|! than|! 3 |! Low |! glucose |! pleural |! fluid/serum |! LCH |! more |! than |! 0.
- What |! is |! obtained |! before |! thoracentesis?: |! Chest |! Xray
- Why |! is |! a |! chest |! xray |! obtained |! before |! thoracentesis?: |! To |! ensure |! that |! the |! pleural |! fluid |! is |! mobile |! and |! accessible |! to |! a |! needle |! place |! in |! the |! pleural |! space.
- How |! do |! you |! diagnose |! Influenza?: |! RNA/DNA |! PCR |! Antibody |! testing- |! front |! line |! testing
- Why |! is |! RNA/DNA |! PCR |! good |! to |! diagnose |! influenza?: |! Because |! its |! very |! spe- |! cific.
- What |! panel |! of |! testing |! is |! the |! RNA/DNA |! PCR |! test?:|! Respiratory |! panel
- Why|! is |! an|! antibody |! test|! not |! as|! good |! as|! a|! PCR |! test|! for |! testing |! influenza?: |! It |! is |! non-specific
- Pulmonary |! Embolus: |! Risk |! Factors: |! How |! much |! bed |! rest |! is |! a |! risk |! factor?: |! 3 |! days
- Pulmonary |! Embolus: |! Risk |! Factors: |! How|! much|! immobility |! is |! a|! risk|! factor?- : |! 8 |! hours
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! age |! is |! risk |! factor?: |! 40+ |! years
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! bed |! rest?:|! Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! extended |! mobility?: |! - Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Increasing |! age?:|! - Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Laparoscopic |! surgery?: |! Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Obesity?: |! Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! pregnancy/ |! antepar- |! tum?: |! Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Varicose |! veins?: |! - Weak
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! are |! the |! odds |! of |! weak |! risk |! fac- |! tors?: |! Less |! than |! 2
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! are |! the |! odds |! of |! medium |! risk |! factors?: |! Less |! than |! 2
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Arthroscopic |! knee |! surgery?: |! Medium
- Pulmonary|! Embolus:|! Risk|! Factors:|! What|! category|! is|! central|! venous|! lines?- : |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! chemotherapy?: |! - Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! CHF |! or |! Respiratory |! Failure?: |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Hormone |! replace- |! ment |! therapy?: |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Oral |! contraceptive |! therapy?: |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! Malignancy?: |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! pregnancy/ |! postpar- |! tum?: |! Medium
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! category |! is |! previous |! VTE?: |! Medi- |! um
- Pulmonary |! Embolus: |! Risk |! Factors: |! What |! are |! the |! odds |! of |! strong |! risk |! fac- |!
Pleurodynia |! (pain |! w/ |! deep |! inhale) |! Tachycardia Hypoxemi a |! S4 |! gallop
- What |! is |! Pleurodynia?: |! Pain |! w/ |! deep |! inhale
- Pulmonary |! Embolus: |! What |! would |! the |! diagnostics |! show?: |! Increased |! D-Dimer Decreased|! Fibrinogen |! V/P |! mismatch low |! PO2 |! and |! high/low |! PCO
|! Reduce |! diffusion |! capacity |! Enlarged |! PA |! on |! CXR |! Increased|! alveolar|! dead|! space |! R |! Ventricular |! dysfunction |! S1Q3T3 |! on |! ECG Pulmonary |! artery |! emboli |! on |! CT
- Pulmonary |! Embolus: |! What |! would |! a |! D-dimer |! show?: |! Increase
- Pulmonary |! Embolus: |! What |! is |! the |! relation |! to |! fibrinogen?: |! Decrease
- Pulmonary |! Embolus: |! What |! would |! is |! V/P?: |! Ventilation/Perfusion |! Scan
